Nexalin Technology (NXL) Debt Ratio (2021)
Nexalin Technology (NXL) posted quarterly Debt Ratio of 0.08 for Q4 2021.
Nexalin Technology (NXL) Debt Ratio (2021) Analysis & Trends
Nexalin Technology's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.08 for Q4 2021.
- In Q4 2021, Debt Ratio changed N/A year-over-year to 0.08; the TTM figure through Dec 2021 stood at 0.08 (changed N/A YoY), while the FY2021 annual figure was 0.08, changed N/A from the prior year.
- Debt Ratio for Q4 2021 stood at 0.08.
- The five-year high for Debt Ratio was 0.08 in Q4 2021, with the low at 0.08 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 0.18 |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.08 |